Marc Hasenfuss Editor-at-large

I wonder how many shareholders in Mediclinic International were celebrating the approval of the company’s acquisition of a controlling stake in Matlosana Medical Health Services. The deal was long delayed by competition issues. And with the National Health Insurance plan casting a pall of uncertainty over the local health-care sector, there might conceivably be punters who wish the deal was blocked.

As the agreement was first announced way back in 2015 it might be a stretch to interpret developments as a strident pronouncement on the future viability of private health care.

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as exclusive Financial Times articles, ProfileData financial data, and digital access to the Sunday Times and Times Select.

Already subscribed? Simply sign in below.

Questions or problems? Email or call 0860 52 52 00. Got a subscription voucher? Redeem it now